True, unbiased discovery in large-scale clinical research is now possible from plasma. Explore every angle of the plasma proteome at unprecedented depth and identify the deepest biological insights for your biomarker discovery.
• Unbiased analysis with unprecedented depth of up to 3,000 of the most relevant proteins
• Unparalleled specificity and quantitative precision
• High-throughput and massively scalable
Plasma proteomics is increasingly recognized as a fundamental approach to accelerate biomarker discovery and drug development, taking precision medicine to the next level.
The brochure provides you with an overview of the key features and benefits of our next-generation Biomarker Discovery solutions. In addition, the brochure elaborates on our deep a [...]
The case study provides you with an overview of the key features and benefits of our next-generation Plasma Biomarker Discovery solution. In addition, the case study elaborates on [...]
Our new White Paper explains how advances in mass spectrometry can now unlock the potential of the plasma proteome, uncovering actionable insights that are essential for biomarker [...]
Cerebrospinal fluid (CSF) is established as a key matrix that enables interrogation of biological processes within the central nervous system. CSF biomarkers may support the develo [...]
Immunotherapy significantly improved treatment options for patients with NSCLC. However, not all patients respond equally if at all. In a joint study with Curie Institute (Paris, F [...]
Tognetti M et al. The plasma proteome has the potential to enable a holistic analysis of the health state of an individual. However, plasma biomarker discovery is difficul [...]
Bruderer R et al. Molecular & Cellular Proteomics. We have established a robust capillary-flow DIA platform capable of measuring a large number of cli [...]